Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus
- Conditions
- Interventions
- First Posted Date
- 2010-08-30
- Last Posted Date
- 2014-07-24
- Lead Sponsor
- Repros Therapeutics Inc.
- Target Recruit Count
- 102
- Registration Number
- NCT01191320
- Locations
- 🇺🇸
LABioMed, Torrance, California, United States
🇺🇸Dr. Bruce Gilbert, Great Neck, New York, United States
🇺🇸TX Urology Associate, Houston, Texas, United States
Determination of the Lowest, Safe and Effective Dose of Proellex
- First Posted Date
- 2010-08-23
- Last Posted Date
- 2014-07-28
- Lead Sponsor
- Repros Therapeutics Inc.
- Target Recruit Count
- 52
- Registration Number
- NCT01187043
- Locations
- 🇺🇸
ICON Devlopment Solutions, San Antonio, Texas, United States
Safety of 25 and 50 mg Proellex® in the Treatment of Women With Symptomatic Uterine Fibroids
- First Posted Date
- 2010-02-17
- Last Posted Date
- 2014-08-21
- Lead Sponsor
- Repros Therapeutics Inc.
- Target Recruit Count
- 27
- Registration Number
- NCT01069120
- Locations
- 🇺🇸
Advances in Health Inc, Houston, Texas, United States
🇺🇸The Women's Hospital of Texas, Clinical Research Center, Houston, Texas, United States
🇺🇸Visions Clinical Research, Boynton Beach, Florida, United States
A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata
- Conditions
- Interventions
- First Posted Date
- 2010-02-17
- Last Posted Date
- 2014-06-30
- Lead Sponsor
- Repros Therapeutics Inc.
- Target Recruit Count
- 29
- Registration Number
- NCT01069094
- Locations
- 🇵🇱
Medical University /MTZ Clinical Research Sp.zo.o., Warsaw, Poland
Proellex Pharmacokinetics Bridging Study
- First Posted Date
- 2010-02-12
- Last Posted Date
- 2014-07-08
- Lead Sponsor
- Repros Therapeutics Inc.
- Target Recruit Count
- 21
- Registration Number
- NCT01067807
- Locations
- 🇺🇸
Healthcare Discoveries, Inc, San Antonio,, Texas, United States
Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism
- First Posted Date
- 2010-02-11
- Last Posted Date
- 2014-06-27
- Lead Sponsor
- Repros Therapeutics Inc.
- Target Recruit Count
- 104
- Registration Number
- NCT01067365
- Locations
- 🇺🇸
Office of Stephen Miller, MD, Las Vegas, Nevada, United States
🇺🇸Northern California Research Corp, Carmichael, California, United States
🇺🇸Harbor-UCLA Medical Center, Torrance, California, United States
Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary Hypogonadism
- Conditions
- Interventions
- First Posted Date
- 2009-08-20
- Last Posted Date
- 2010-02-11
- Lead Sponsor
- Repros Therapeutics Inc.
- Target Recruit Count
- 194
- Registration Number
- NCT00962637
- Locations
- 🇺🇸
Northeast Indiana Research, LLC, Fort Wayne, Indiana, United States
🇺🇸Salt Lake Research, Salt Lake City, Utah, United States
🇺🇸Southeastern Research Group, Inc., Tallahassee, Florida, United States
Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003
- First Posted Date
- 2009-08-13
- Last Posted Date
- 2019-06-18
- Lead Sponsor
- Repros Therapeutics Inc.
- Target Recruit Count
- 65
- Registration Number
- NCT00958334
- Locations
- 🇺🇸
Arizona Wellness Centre for Women, Phoenix, Arizona, United States
🇺🇸Medical Centre for Clinical Research, San Diego, California, United States
🇺🇸Women's Health Care, Inc., San Diego, California, United States
Study Evaluating the Safety and Efficacy of Proellex® in the Treatment of Endometriosis-extension Study
- First Posted Date
- 2009-08-13
- Last Posted Date
- 2019-02-12
- Lead Sponsor
- Repros Therapeutics Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT00958412
- Locations
- 🇺🇸
Clinical Trials of Texas/Institute for Women's Health, San Antonio, Texas, United States
🇺🇸Medical Center for Clinical Research, San Diego, California, United States
🇺🇸Comprehensive Clinical Trials, West Palm Beach, Florida, United States
An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 Ext
- First Posted Date
- 2009-08-13
- Last Posted Date
- 2014-08-25
- Lead Sponsor
- Repros Therapeutics Inc.
- Target Recruit Count
- 4
- Registration Number
- NCT00958893
- Locations
- 🇺🇸
Advances in Health, Inc., Houston,, Texas, United States